Casdin Capital, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 39 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$12,099,000
-17.2%
1,154,476
-7.0%
0.31%
-29.4%
Q1 2021$14,621,000
+0.6%
1,241,1760.0%0.44%
+0.9%
Q4 2020$14,534,000
+27.2%
1,241,176
-13.9%
0.43%
-15.8%
Q3 2020$11,429,000
-56.6%
1,441,1760.0%0.51%
-67.2%
Q2 2020$26,359,000
+82.6%
1,441,176
+19.2%
1.56%
+1.8%
Q1 2020$14,439,000
-30.0%
1,209,285
-2.4%
1.53%
-19.1%
Q4 2019$20,622,000
-99.6%
1,239,285
+46.8%
1.90%
+226.9%
Q3 2019$5,606,052,000844,2850.58%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders